Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifamycin Sodium Injection

Approval Number

国药准字H20045088

Company江西赣南海欣药业股份有限公司

Registration Date

July 18, 2022

Previous Approval Numbers

国药准字H20045088

Drug Information

Generic Name

利福霉素钠注射液

Dosage Form

注射剂

Strength

5ml:0.25g(25万单位)

Drug Type

化学药品

Registration Date

July 18, 2022

Company Information

Applicant Company

Company Name江西赣南海欣药业股份有限公司

Company Address

江西省赣州市赣州经济技术开发区湖边大道209号

Manufacturing Company

Company Name江西赣南海欣药业股份有限公司

Company Address

江西省赣州市赣州经济技术开发区湖边大道209号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利福霉素钠注射液 - NMPA 批准文号 | MedPath